Cellular Components of the Tumor Environment in Gliomas-What Do We Know Today?

Reinhold Nafe, Elke Hattingen
Author Information
  1. Reinhold Nafe: Department of Neuroradiology, Clinics of Johann Wolfgang Goethe-University, Schleusenweg 2-16, D-60528 Frankfurt am Main, Germany.
  2. Elke Hattingen: Department of Neuroradiology, Clinics of Johann Wolfgang Goethe-University, Schleusenweg 2-16, D-60528 Frankfurt am Main, Germany. ORCID

Abstract

A generation ago, the molecular properties of tumor cells were the focus of scientific interest in oncology research. Since then, it has become increasingly apparent that the tumor environment (TEM), whose major components are non-neoplastic cell types, is also of utmost importance for our understanding of tumor growth, maintenance and resistance. In this review, we present the current knowledge concerning all cellular components within the TEM in gliomas, focusing on their molecular properties, expression patterns and influence on the biological behavior of gliomas. Insight into the TEM of gliomas has expanded considerably in recent years, including many aspects that previously received only marginal attention, such as the phenomenon of phagocytosis of glioma cells by macrophages and the role of the thyroid-stimulating hormone on glioma growth. We also discuss other topics such as the migration of lymphocytes into the tumor, phenotypic similarities between chemoresistant glioma cells and stem cells, and new clinical approaches with immunotherapies involving the cells of TEM.

Keywords

References

  1. Nature. 2010 Dec 9;468(7325):824-8 [PMID: 21102434]
  2. PLoS One. 2011;6(8):e23902 [PMID: 21901144]
  3. PLoS One. 2020 May 29;15(5):e0233617 [PMID: 32469935]
  4. Nat Commun. 2023 Feb 23;14(1):1028 [PMID: 36823172]
  5. J Immunol. 2012 Jul 1;189(1):444-53 [PMID: 22664874]
  6. Discov Oncol. 2023 Aug 11;14(1):148 [PMID: 37566174]
  7. Int J Biol Sci. 2023 Jul 24;19(12):3762-3780 [PMID: 37564196]
  8. J Transl Autoimmun. 2020 Nov 12;3:100070 [PMID: 33294833]
  9. Oncogene. 2021 Aug;40(32):5081-5094 [PMID: 34188250]
  10. Brain Pathol. 2024 Jan;34(1):e13203 [PMID: 37574201]
  11. Front Oncol. 2023 Jun 05;13:1176448 [PMID: 37342189]
  12. Cancer Discov. 2019 Nov;9(11):1556-1573 [PMID: 31455674]
  13. Aging (Albany NY). 2020 Dec 9;13(2):2397-2417 [PMID: 33318300]
  14. Trends Cell Biol. 2021 Nov;31(11):940-950 [PMID: 34272133]
  15. Int J Mol Sci. 2023 Aug 11;24(16): [PMID: 37628853]
  16. Clin Cancer Res. 2018 Sep 1;24(17):4175-4186 [PMID: 29437767]
  17. Front Physiol. 2013 Nov 01;4:316 [PMID: 24198789]
  18. Cell Stem Cell. 2019 Aug 1;25(2):241-257.e8 [PMID: 31303549]
  19. PLoS One. 2011;6(9):e25222 [PMID: 21949886]
  20. Mol Cancer. 2020 Mar 25;19(1):66 [PMID: 32213181]
  21. Cancer Sci. 2022 Feb;113(2):756-769 [PMID: 34881489]
  22. Nature. 2015 Nov 5;527(7576):100-104 [PMID: 26479035]
  23. Biosci Rep. 2020 Apr 30;40(4): [PMID: 32232385]
  24. Mol Immunol. 2022 Feb;142:1-10 [PMID: 34953280]
  25. J Transl Med. 2021 Mar 6;19(1):99 [PMID: 33676540]
  26. Acta Neuropathol. 2012 Nov;124(5):599-614 [PMID: 22825593]
  27. Int J Mol Sci. 2022 Nov 17;23(22): [PMID: 36430704]
  28. J Clin Invest. 2017 Apr 3;127(4):1425-1437 [PMID: 28319047]
  29. Contemp Oncol (Pozn). 2016;20(5):345-351 [PMID: 28373814]
  30. Front Cell Dev Biol. 2021 Apr 30;9:654407 [PMID: 33996815]
  31. Int J Mol Sci. 2022 Dec 09;23(24): [PMID: 36555253]
  32. Life Sci. 2023 Oct 15;331:122024 [PMID: 37574043]
  33. J Neuroimmunol. 2014 Sep 15;274(1-2):71-7 [PMID: 25042352]
  34. J Transl Med. 2020 Aug 6;18(1):305 [PMID: 32762688]
  35. Br J Pharmacol. 2019 Aug;176(15):2691-2707 [PMID: 31034096]
  36. Oncogene. 2016 Mar 24;35(12):1504-16 [PMID: 26165844]
  37. Mol Med. 2012 May 09;18:519-27 [PMID: 22294205]
  38. Front Immunol. 2022 Feb 21;13:841404 [PMID: 35265085]
  39. Nature. 2014 Sep 25;513(7519):559-63 [PMID: 25043024]
  40. Molecules. 2021 May 05;26(9): [PMID: 34063013]
  41. Cancer Immunol Res. 2022 Jun 3;10(6):770-784 [PMID: 35413115]
  42. Hypertension. 2021 Nov;78(5):1185-1196 [PMID: 34601963]
  43. Nat Commun. 2019 Jan 25;10(1):448 [PMID: 30683885]
  44. Signal Transduct Target Ther. 2021 Oct 7;6(1):362 [PMID: 34620838]
  45. Nat Commun. 2021 Jul 5;12(1):4127 [PMID: 34226552]
  46. J Neuropathol Exp Neurol. 2020 Jan 1;79(1):74-85 [PMID: 31819973]
  47. Acta Neuropathol. 2013 Apr;125(4):609-20 [PMID: 23344256]
  48. Cell Res. 2021 Jun;31(6):684-702 [PMID: 33390587]
  49. Nature. 2020 Jan;577(7792):689-694 [PMID: 31942068]
  50. Mol Oncol. 2022 Dec;16(22):3927-3948 [PMID: 36134697]
  51. Neuro Oncol. 2016 Jun;18(6):807-18 [PMID: 26578623]
  52. J Neurooncol. 2017 Sep;134(3):505-512 [PMID: 28233083]
  53. Trends Neurosci. 2021 Mar;44(3):215-226 [PMID: 33234347]
  54. Cancer Res. 2016 May 15;76(10):2954-63 [PMID: 26980765]
  55. Sci Transl Med. 2023 Apr 12;15(691):eadd1016 [PMID: 37043555]
  56. Cancer Immunol Immunother. 2012 May;61(5):701-11 [PMID: 22057676]
  57. Clin Cancer Res. 2016 Nov 1;22(21):5277-5286 [PMID: 27166395]
  58. Brain. 2022 Sep 14;145(9):3288-3307 [PMID: 35899587]
  59. Neuro Oncol. 2013 Nov;15(11):1457-68 [PMID: 24014382]
  60. Neuro Oncol. 2023 May 4;25(5):813-826 [PMID: 36632791]
  61. BMC Cancer. 2022 May 9;22(1):523 [PMID: 35534796]
  62. Oncotarget. 2017 Apr 11;8(15):24815-24827 [PMID: 28445977]
  63. Clin Cancer Res. 2018 Aug 15;24(16):3792-3802 [PMID: 29593027]
  64. Adv Mater. 2023 Feb;35(7):e2208782 [PMID: 36427266]
  65. J Neurosci. 2021 Sep 15;41(37):7698-7711 [PMID: 34526407]
  66. Cancer Res. 2018 Apr 1;78(7):1833-1844 [PMID: 29437039]
  67. Mol Cancer. 2014 May 15;13:108 [PMID: 24886454]
  68. J Neurooncol. 2021 Jan;151(1):3-12 [PMID: 32542437]
  69. Signal Transduct Target Ther. 2023 Nov 8;8(1):424 [PMID: 37935665]
  70. J Cancer Res Clin Oncol. 2023 Nov;149(14):13185-13200 [PMID: 37479756]
  71. Semin Cell Dev Biol. 2012 Jun;23(4):389-94 [PMID: 22525300]
  72. Cancer Res. 2016 Oct 1;76(19):5597-5601 [PMID: 27634765]
  73. Clin Cancer Res. 2022 Feb 1;28(3):498-506 [PMID: 35105718]
  74. Nat Rev Neurol. 2018 Aug;14(8):482-495 [PMID: 29985475]
  75. Cancer Lett. 2016 Oct 1;380(2):545-551 [PMID: 25527451]
  76. Front Immunol. 2020 Oct 30;11:592389 [PMID: 33193439]
  77. Front Cell Dev Biol. 2021 Oct 29;9:721897 [PMID: 34778248]
  78. Transl Oncol. 2020 Oct;13(10):100819 [PMID: 32622311]
  79. Nature. 2010 Dec 9;468(7325):829-33 [PMID: 21102433]
  80. Neuro Oncol. 2022 Oct 3;24(10):1647-1657 [PMID: 35325210]
  81. Mol Ther. 2021 Dec 1;29(12):3449-3464 [PMID: 34217892]
  82. Biomark Res. 2020 Nov 11;8(1):64 [PMID: 33292666]
  83. Mol Imaging. 2015;14:414-28 [PMID: 26431589]
  84. Oncotarget. 2016 Nov 8;7(45):73971-73983 [PMID: 27738332]
  85. Mol Cancer. 2022 Sep 26;21(1):184 [PMID: 36163047]
  86. J Clin Invest. 2019 Jan 2;129(1):137-149 [PMID: 30307407]
  87. Front Immunol. 2022 Oct 06;13:974996 [PMID: 36275720]
  88. Cell Rep. 2023 Feb 28;42(2):112127 [PMID: 36795563]
  89. Int J Mol Sci. 2023 Apr 30;24(9): [PMID: 37175798]
  90. Int J Mol Sci. 2020 Nov 11;21(22): [PMID: 33187183]
  91. Curr Opin Neurol. 2021 Dec 1;34(6):868-874 [PMID: 34581301]
  92. Philos Trans R Soc Lond B Biol Sci. 2018 Jan 5;373(1737): [PMID: 29158308]
  93. J Oncol. 2013;2013:486912 [PMID: 23737783]
  94. J Exp Med. 2021 Jan 4;218(1): [PMID: 32991668]
  95. Cancer Res. 2022 Nov 15;82(22):4274-4287 [PMID: 36126163]
  96. Mol Med Rep. 2016 Feb;13(2):1329-35 [PMID: 26676970]
  97. J Immunother Cancer. 2022 Jan;10(1): [PMID: 35101946]
  98. Neuro Oncol. 2012 May;14(5):584-95 [PMID: 22406925]
  99. Med Oncol. 2022 Jun 18;39(9):130 [PMID: 35716323]
  100. Neurosci Bull. 2015 Jun;31(3):371-8 [PMID: 25913038]
  101. Clin Cancer Res. 2012 Nov 15;18(22):6110-21 [PMID: 22932670]
  102. Biomolecules. 2020 Aug 31;10(9): [PMID: 32878087]
  103. Neuro Oncol. 2019 Oct 9;21(10):1250-1262 [PMID: 31111915]
  104. Oncoimmunology. 2015 Jun 5;4(9):e1036211 [PMID: 26405601]
  105. Cells. 2020 Dec 24;10(1): [PMID: 33374253]
  106. Nature. 2015 Jul 16;523(7560):337-41 [PMID: 26030524]
  107. Cancer Cell. 2020 May 11;37(5):630-636 [PMID: 32396858]
  108. Trends Cancer. 2023 Apr;9(4):270-292 [PMID: 36681605]
  109. Neurosurg Clin N Am. 2021 Apr;32(2):283-289 [PMID: 33781508]
  110. JAMA Oncol. 2023 Jan 1;9(1):112-121 [PMID: 36394838]
  111. Nat Commun. 2014 Jun 19;5:4196 [PMID: 24943270]
  112. J Clin Oncol. 2023 Mar 1;41(7):1453-1465 [PMID: 36521103]
  113. Int J Oncol. 2015 Jul;47(1):91-6 [PMID: 25955568]
  114. Cancers (Basel). 2023 Feb 15;15(4): [PMID: 36831580]
  115. Cell Physiol Biochem. 2017;44(5):1741-1748 [PMID: 29216623]
  116. Sci Rep. 2017 Dec 14;7(1):17556 [PMID: 29242629]
  117. Sci Rep. 2018 May 16;8(1):7654 [PMID: 29769580]
  118. J Clin Invest. 2023 Mar 1;133(5): [PMID: 36856115]
  119. Int J Oncol. 2003 Aug;23(2):353-61 [PMID: 12851684]
  120. Sci Rep. 2021 Jul 15;11(1):14556 [PMID: 34267246]
  121. JCI Insight. 2018 Nov 2;3(21): [PMID: 30385717]
  122. J Clin Invest. 2010 Apr;120(4):1151-64 [PMID: 20237412]
  123. CNS Neurosci Ther. 2023 Apr;29(4):988-999 [PMID: 36377508]
  124. J Exp Clin Cancer Res. 2015 May 14;34:44 [PMID: 25967234]
  125. Cell. 2021 Mar 4;184(5):1281-1298.e26 [PMID: 33592174]
  126. Neuro Oncol. 2010 Jan;12(1):7-13 [PMID: 20150362]
  127. Int J Mol Sci. 2020 Dec 27;22(1): [PMID: 33375505]
  128. J Neuropathol Exp Neurol. 2017 Jan 1;76(1):16-26 [PMID: 28040794]
  129. Clin Cancer Res. 2014 Jan 1;20(1):187-98 [PMID: 24240114]
  130. Neurobiol Dis. 2020 Jul;141:104942 [PMID: 32423877]
  131. Nat Neurosci. 2016 Jan;19(1):20-7 [PMID: 26713745]
  132. Mol Cancer Res. 2022 Feb;20(2):319-331 [PMID: 34654721]
  133. Immunology. 2023 Feb;168(2):233-247 [PMID: 35719015]
  134. Cell. 2015 May 7;161(4):803-16 [PMID: 25913192]
  135. Nat Commun. 2022 Oct 20;13(1):6211 [PMID: 36266311]
  136. Cancer Immunol Res. 2019 Dec;7(12):1928-1943 [PMID: 31530559]
  137. Nat Neurosci. 2011 Jun;14(6):736-43 [PMID: 21532577]
  138. Cancers (Basel). 2022 Feb 25;14(5): [PMID: 35267518]
  139. Mol Cancer. 2023 Aug 10;22(1):129 [PMID: 37563568]
  140. J Exp Med. 1996 Jul 1;184(1):1-8 [PMID: 8691122]
  141. Nature. 2023 Jul;619(7971):844-850 [PMID: 37380778]
  142. Curr Opin Neurol. 2022 Dec 1;35(6):794-802 [PMID: 36226710]
  143. J Transl Med. 2023 May 27;21(1):350 [PMID: 37245011]
  144. Molecules. 2021 Oct 12;26(20): [PMID: 34684726]
  145. Oncotarget. 2015 Sep 15;6(27):23647-61 [PMID: 26164207]
  146. Neurooncol Adv. 2021 May 04;3(1):vdab031 [PMID: 34286275]
  147. Nat Rev Neurol. 2015 Sep;11(9):504-14 [PMID: 26260659]
  148. Theranostics. 2021 Jan 1;11(2):665-683 [PMID: 33391498]
  149. Brain. 2022 Oct 21;145(10):3666-3680 [PMID: 35552612]
  150. Turk Neurosurg. 2022;32(3):357-363 [PMID: 35615767]
  151. Sci Rep. 2022 Oct 22;12(1):17781 [PMID: 36273031]
  152. Int J Mol Sci. 2021 Dec 08;22(24): [PMID: 34948008]
  153. Front Genet. 2022 Aug 24;13:897083 [PMID: 36092895]
  154. Theranostics. 2021 Sep 27;11(19):9687-9704 [PMID: 34646393]
  155. J Cereb Blood Flow Metab. 2008 Jan;28(1):90-8 [PMID: 17519976]
  156. Cancer Metastasis Rev. 2022 Mar;41(1):53-75 [PMID: 34687436]
  157. Neuro Oncol. 2023 Feb 14;25(2):263-276 [PMID: 35609569]
  158. Genes Dev. 2015 Jun 15;29(12):1203-17 [PMID: 26109046]
  159. Cancer Res. 2023 Mar 2;83(5):771-785 [PMID: 36622331]
  160. Oncotarget. 2017 Apr 4;8(14):22325-22343 [PMID: 28423611]
  161. Nature. 2022 Mar;603(7903):934-941 [PMID: 35130560]
  162. J Immunol. 2006 Feb 15;176(4):2279-91 [PMID: 16455984]

Word Cloud

Created with Highcharts 10.0.0cellstumorTEMgliomasgliomamolecularpropertiesenvironmentcomponentsalsogrowthmacrophageslymphocytesgenerationagofocusscientificinterestoncologyresearchSincebecomeincreasinglyapparentwhosemajornon-neoplasticcelltypesutmostimportanceunderstandingmaintenanceresistancereviewpresentcurrentknowledgeconcerningcellularwithinfocusingexpressionpatternsinfluencebiologicalbehaviorInsightexpandedconsiderablyrecentyearsincludingmanyaspectspreviouslyreceivedmarginalattentionphenomenonphagocytosisrolethyroid-stimulatinghormonediscusstopicsmigrationphenotypicsimilaritieschemoresistantstemnewclinicalapproachesimmunotherapiesinvolvingCellularComponentsTumorEnvironmentGliomas-WhatKnowToday?astrocytescancer-associatedfibroblastsdendriticmyeloid-derivedsuppressorneuronsneutrophilstumor-associated

Similar Articles

Cited By